MedTrace Logo

Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost

NCT01645865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2014-11-13

No results posted yet for this study

Summary

Although gains have been made in achieving the health-related Millennium Development Goals (MDG), much is still needed in countries affected by high levels of HIV/AIDS. Prevention of mother-to-child transmission (PMTCT) is a cornerstone strategy in reducing infant mortality from HIV. The study will employ a cluster randomized control trial (cRCT) with 26 health facilities randomized to two arms (intervention or control) to determine the effect of mobile phone technology on completion of key PMTCT milestones from antenatal to six weeks postpartum. The study will examine the acceptability, effectiveness, and cost of implementing a PMTCT-focused mHealth strategy among HIV-infected pregnant women, health workers, and male partners.

Conditions

  • HIV
  • HIV Infections
  • AIDS
  • Antiretroviral Therapy

Interventions

BEHAVIORAL

Control

Health facilities where PMTCT services are available in the traditional clinical setting with HIV testing and counseling, PMTCT support, and enrollment in care and treatment.

BEHAVIORAL

Intervention

In addition to the 'Standard of Care', HIV-infected pregnant women and male partners within the PMTCT program are engaged in multi-directional mobile communication for PMTCT promotion with health care providers.

Sponsors & Collaborators

  • World Health Organization, Alliance for Health Policy and Systems Research

    collaborator UNKNOWN

  • Kenya National AIDS & STI Control Programme

    collaborator OTHER

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • John Ong'ech, MBChB, MMed, MPH · Elizabeth Glaser Pediatric AIDS Foundation, UON/KNH

  • Seble Kassaye, MD, MS · Elizabeth Glaser Pediatric AIDS Foundation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645865 on ClinicalTrials.gov